tiprankstipranks
Trending News
More News >
Amn Healthcare Services Inc (AMN)
NYSE:AMN
Advertisement

AMN Healthcare Services (AMN) AI Stock Analysis

Compare
534 Followers

Top Page

AMN

AMN Healthcare Services

(NYSE:AMN)

Select Model
Select Model
Select Model
Neutral 50 (OpenAI - 4o)
Rating:50Neutral
Price Target:
$18.50
▲(3.53% Upside)
AMN Healthcare Services' overall stock score is primarily impacted by its financial performance challenges, including declining revenue and profitability, high leverage, and reduced cash flow efficiency. Technical indicators suggest a bearish trend, and valuation metrics are weak due to negative earnings. However, the recent earnings call provided some positive insights, such as exceeding revenue expectations and improved client satisfaction, which slightly mitigate the negative aspects.
Positive Factors
Revenue Exceeding Expectations
Exceeding revenue expectations indicates strong demand and effective execution, which can lead to sustained growth and market confidence.
Debt Refinancing
Refinancing debt improves financial flexibility and reduces near-term financial risk, supporting long-term stability and growth.
Improved Client Satisfaction
Higher client satisfaction can lead to increased client retention and new business opportunities, bolstering long-term revenue streams.
Negative Factors
Declining Revenue
Continued revenue decline suggests challenges in market demand or competitive positioning, potentially impacting future growth prospects.
High Leverage
High leverage can limit financial flexibility and increase risk, especially if cash flow generation does not improve to cover debt obligations.
Gross Margin Decline
A declining gross margin indicates pricing pressures and cost management issues, which could erode profitability if not addressed.

AMN Healthcare Services (AMN) vs. SPDR S&P 500 ETF (SPY)

AMN Healthcare Services Business Overview & Revenue Model

Company DescriptionAMN Healthcare Services, Inc. is a leading provider of healthcare workforce solutions and staffing services in the United States. The company specializes in temporary and permanent placement of healthcare professionals, including nurses, physicians, allied health professionals, and other clinical staff. AMN operates in various sectors such as travel nursing, locum tenens, and healthcare technology, offering innovative solutions that address the staffing needs of healthcare facilities across the nation.
How the Company Makes MoneyAMN Healthcare generates revenue primarily through its staffing and workforce solutions services. The company earns money by charging healthcare facilities for the provision of temporary and permanent staffing services, typically on a per-hour or per-placement basis. Key revenue streams include travel nursing, locum tenens staffing, and other allied healthcare staffing solutions. Additionally, AMN offers workforce management solutions and technology services, which contribute to its earnings. Significant partnerships with hospitals, healthcare systems, and other organizations enhance its market presence and drive revenue growth, as these collaborations often lead to long-term contracts and stable income streams.

AMN Healthcare Services Earnings Call Summary

Earnings Call Date:Nov 06, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Feb 12, 2026
Earnings Call Sentiment Positive
The earnings call highlighted several positive aspects, such as exceeding revenue and EBITDA expectations, strong demand recovery, and improved financial and client satisfaction measures. However, it also noted challenges, including declines in gross margin, and specific business segments facing revenue decreases and pricing pressures. Overall, the highlights slightly outweigh the lowlights.
Q3-2025 Updates
Positive Updates
Revenue Above Guidance
Third quarter revenue of $634 million was $9 million above the high end of the guidance range.
Adjusted EBITDA Exceeds Expectations
Adjusted EBITDA for the third quarter was $57.5 million, 90 basis points above the high end of the guidance range.
Strong Demand Recovery
Staffing demand recovered moderately in the third quarter, with extension rates rebounding and Travel Nurse winter orders slightly favorable compared to the prior year.
Debt Refinancing Improves Financial Position
Completed a debt refinancing transaction that extended the earliest debt expiration to 2029, improved the corporate debt rating, and increased operating flexibility.
Improved Client Satisfaction
Achieved a 700 basis point year-over-year improvement in client satisfaction, with significant improvement in Net Promoter Scores.
Negative Updates
Gross Margin Decline
Consolidated gross margin declined due to an unfavorable revenue mix shift and competitive pressures in Staffing and Language services.
Technology and Workforce Solutions Revenue Drop
Third quarter revenue in Technology and Workforce Solutions was $7 million lower than the prior quarter, primarily due to the sale of the Smart Square business.
Nurse and Allied Revenue Decrease
Nurse and Allied revenue was $361 million, down 9% from the prior year, although exceeding the high end of the guidance range.
Language Services Pricing Pressure
Experienced pricing pressure in Language Services, with revenue less than $1 million lower than the previous quarter.
Company Guidance
During AMN Healthcare's third-quarter 2025 earnings call, the company reported a revenue of $634 million, which was $9 million above the high end of their guidance range. The consolidated gross margin was near the upper end of guidance, while SG&A expenses were better than expected. Adjusted EBITDA for the quarter stood at $57.5 million, representing 9.1% of revenue, which was 90 basis points above the high end of guidance. The company noted a moderate recovery in staffing demand, with Travel Nurse winter orders slightly exceeding the prior year's figures. However, permanent hiring activity in the healthcare sector fell significantly. Bill rates for Nurse and Allied Staffing are expected to rise modestly year-over-year in the fourth quarter, marking the first increase in three years. For the fourth quarter, AMN projects revenue to be just over $720 million, with an additional $100 million anticipated from Labor Disruption revenue. Despite varying conditions across business lines, all three segments exceeded consensus revenue estimates, particularly the Nurse and Allied Solutions segment, which saw a $12 million upside. The company's strategic focus remains on expanding service lines and improving client retention, supported by a significant 700 basis point year-over-year improvement in client satisfaction.

AMN Healthcare Services Financial Statement Overview

Summary
AMN Healthcare Services is facing financial challenges with declining revenue and profitability. The income statement shows negative revenue growth and profit margins, while the balance sheet indicates high leverage. Despite these issues, cash flow remains a relative strength, providing some liquidity.
Income Statement
AMN Healthcare Services has faced declining revenue and profitability in recent periods. The TTM data shows a negative revenue growth rate of -2.89% and a net profit margin of -10.75%, indicating significant challenges in maintaining profitability. Historical data shows a downward trend in revenue and profit margins, with EBIT and EBITDA margins turning negative in the TTM period.
Balance Sheet
The company's balance sheet reflects high leverage, with a debt-to-equity ratio of 1.57 in the TTM period, indicating potential financial risk. The return on equity has turned negative, reflecting recent losses. However, the equity ratio remains stable, suggesting some balance sheet resilience despite recent challenges.
Cash Flow
Cash flow analysis shows a decline in free cash flow growth, with a negative growth rate of -135.2% in the TTM period. However, the company maintains a relatively healthy free cash flow to net income ratio of 0.82, indicating some ability to generate cash despite net losses. Operating cash flow remains positive, providing some liquidity cushion.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue2.72B2.98B3.79B5.24B3.98B2.39B
Gross Profit797.92M919.38M1.25B1.72B1.31B791.78M
EBITDA-135.20M71.11M499.36M784.21M581.70M243.45M
Net Income-275.54M-146.98M210.68M444.05M327.39M70.67M
Balance Sheet
Total Assets2.14B2.42B2.92B2.89B3.13B2.35B
Cash, Cash Equivalents and Short-Term Investments52.64M10.65M32.94M64.52M180.93M29.21M
Total Debt846.76M1.10B1.35B860.96M867.07M955.48M
Total Liabilities1.49B1.71B2.09B1.84B1.97B1.53B
Stockholders Equity644.41M706.62M831.26M1.04B1.16B819.68M
Cash Flow
Free Cash Flow222.80M239.53M266.78M572.81M251.69M217.72M
Operating Cash Flow266.70M320.42M372.17M653.73M305.36M256.83M
Investing Cash Flow-67.26M-79.94M-412.49M-170.71M-107.40M-538.17M
Financing Cash Flow-79.90M-259.45M10.73M-591.87M-34.90M211.49M

AMN Healthcare Services Technical Analysis

Technical Analysis Sentiment
Negative
Last Price17.87
Price Trends
50DMA
19.61
Negative
100DMA
19.76
Negative
200DMA
21.33
Negative
Market Momentum
MACD
-0.15
Positive
RSI
38.66
Neutral
STOCH
29.62
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AMN, the sentiment is Negative. The current price of 17.87 is below the 20-day moving average (MA) of 19.98, below the 50-day MA of 19.61, and below the 200-day MA of 21.33, indicating a bearish trend. The MACD of -0.15 indicates Positive momentum. The RSI at 38.66 is Neutral, neither overbought nor oversold. The STOCH value of 29.62 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AMN.

AMN Healthcare Services Risk Analysis

AMN Healthcare Services disclosed 29 risk factors in its most recent earnings report. AMN Healthcare Services reported the most risks in the "Production" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

AMN Healthcare Services Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
$1.23B31.948.07%6.26%-19.33%
61
Neutral
$1.67B132.651.29%68.17%-85.23%
54
Neutral
$1.92B114.7615.48%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
50
Neutral
$790.63M-35.90%-11.42%-617.31%
49
Neutral
$394.76M-46.54-1.96%-24.30%-210.27%
44
Neutral
$28.71K-0.70%-2.38%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AMN
AMN Healthcare Services
17.87
-11.18
-38.49%
CCRN
Cross Country Healthcare
12.37
2.01
19.40%
HCSG
Healthcare Services
17.26
5.39
45.41%
MODVQ
ModivCare
0.10
-15.45
-99.36%
ASTH
Astrana Health
25.54
-21.42
-45.61%
AVAH
Aveanna Healthcare Holdings
8.75
2.92
50.09%

AMN Healthcare Services Corporate Events

AMN Healthcare Exceeds Earnings Expectations Amid Challenges
Nov 8, 2025

AMN Healthcare’s recent earnings call painted a generally positive picture, with the company surpassing revenue and EBITDA expectations, and experiencing a strong demand recovery. While there were challenges such as declines in gross margin and specific segments facing revenue decreases, the overall sentiment was optimistic, with highlights slightly outweighing the lowlights.

AMN Healthcare Reports Mixed Q3 2025 Results
Nov 7, 2025

AMN Healthcare Services, Inc. is a leading provider of total talent solutions for healthcare organizations across the United States, offering a comprehensive suite of workforce technologies and a network of healthcare professionals.

Business Operations and StrategyPrivate Placements and Financing
AMN Healthcare Issues $400M Senior Notes for Refinancing
Positive
Oct 6, 2025

On October 6, 2025, AMN Healthcare, Inc., a subsidiary of AMN Healthcare Services, Inc., issued $400 million in 6.500% Senior Notes due in 2031. This issuance, part of a strategic financial maneuver, is aimed at refinancing existing debt and optimizing the company’s capital structure. Concurrently, the company amended its existing credit agreement, reducing its revolving credit facility from $750 million to $450 million and extending its maturity to 2030. These actions are expected to enhance financial flexibility and support the company’s long-term growth objectives.

The most recent analyst rating on (AMN) stock is a Buy with a $20.00 price target. To see the full list of analyst forecasts on AMN Healthcare Services stock, see the AMN Stock Forecast page.

Business Operations and StrategyPrivate Placements and Financing
AMN Healthcare Announces $400M Senior Notes Offering
Positive
Sep 22, 2025

On September 22, 2025, AMN Healthcare announced an unregistered offering of $400 million in senior unsecured notes due 2031, with the proceeds intended to redeem $500 million of notes due 2027 and cover related expenses. This strategic financial move aims to optimize the company’s debt structure, potentially enhancing its financial flexibility and market positioning.

The most recent analyst rating on (AMN) stock is a Hold with a $20.00 price target. To see the full list of analyst forecasts on AMN Healthcare Services stock, see the AMN Stock Forecast page.

Business Operations and StrategyPrivate Placements and Financing
AMN Healthcare Services Amends Credit Agreement Terms
Neutral
Sep 22, 2025

AMN Healthcare Services announced plans to amend its existing Credit Agreement, originally dated February 9, 2018. The amendment will extend the maturity of its revolving credit facility to October 2030, reduce its size from $750 million to $450 million, and adjust the credit spread and leverage ratio terms. The final documentation for this amendment is expected to be executed in the fourth quarter of 2025, potentially impacting the company’s financial flexibility and operational strategy.

The most recent analyst rating on (AMN) stock is a Hold with a $20.00 price target. To see the full list of analyst forecasts on AMN Healthcare Services stock, see the AMN Stock Forecast page.

AMN Healthcare’s Mixed Earnings Call: Strong Performance Amid Challenges
Aug 12, 2025

The recent earnings call for AMN Healthcare painted a mixed picture, showcasing both strong financial performance and strategic initiatives, while also highlighting some challenges. The company reported robust financial results and strategic advancements, such as the AMN Passport and AI technology, which were key positives. However, concerns were raised due to revenue declines, particularly in the Travel Nurse segment, and significant impairment charges. Despite these challenges, strategic debt reduction and anticipated growth in international staffing offer a glimmer of optimism for the future.

AMN Healthcare Reports Q2 2025 Financial Results
Aug 8, 2025

AMN Healthcare Services, Inc. is a leading provider of total talent solutions for healthcare organizations across the United States, offering a comprehensive network of healthcare professionals and workforce technologies.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 08, 2025